BDIMI-C 250
Brand Name: BDIMI-C 250
Generic Name: Imipenem + Cilastatin Sodium
Active
Registration Number
DRP-9909
Dosage Form
Powder for Injection (IV)
Issuance Date
March 1, 2024
Expiry Date
November 20, 2029
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength250 mg/ 250 mg
Packaging20 mL USP Type I Glass Vial (Box of 1's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (2)
Complete list of active ingredients in this pharmaceutical product.
ImipenemActive
Monograph: Imipenem
Cilastatin SodiumActive
Monograph: Cilastatin